Selepressin, a novel selective vasopressin V 1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

Vasopressin is widely used for vasopressor support in septic shock patients, but experimental evidence suggests that selective V agonists are superior. The initial pharmacodynamic effects, pharmacokinetics, and safety of selepressin, a novel V -selective vasopressin analogue, was examined in a phase...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Critical care (London, England) England), 2017-08, Vol.21 (1), p.213
Hauptverfasser:	Russell, James A, Vincent, Jean-Louis, Kjølbye, Anne Louise, Olsson, Håkan, Blemings, Allan, Spapen, Herbert, Carl, Peder, Laterre, Pierre-Francois, Grundemar, Lars
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!